North America Colorectal Cancer Market Size, Trends, Competitors Strategy, Regional Analysis and Growth by Forecast to 2028
The colorectal cancer market in North America is expected to
grow from US$ 8,559.27 million in 2022 to US$ 11,198.11 million by 2028; it is
estimated to grow at a CAGR of 3.4% from 2022 to 2028.
Colorectal cancer is one of the most commonly found lethal
cancers in individuals with the combined influence of genetic and environmental
factors. A significant population in North America is diagnosed with colorectal
cancer. According to the Centers for Disease Control and Prevention (CDC) and
the American Cancer Society, an estimated 1.93 million adults in the US were
diagnosed with colon and rectum cancer, and 53,200 deaths were caused by
colorectal cancer in 2020. These statistics showcase increased demand for
advanced cancer diagnostics and therapeutics in the region. Thus, the rising
prevalence of colorectal cancer and the rising number of patients diagnosed
with the disease are driving the growth of the North America colorectal cancer
market.
With the new features and technologies, vendors can attract
new customers and expand their footprints in emerging markets. This factor is
likely to drive the North America colorectal cancer market at a substantial
CAGR during the forecast period.
📚 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝
𝐒𝐚𝐦𝐩𝐥𝐞
𝐏𝐃𝐅
𝐂𝐨𝐩𝐲@
https://www.businessmarketinsights.com/sample/TIPRE00009241
North America Colorectal Cancer
Strategic Insights
Strategic insights for the North America Colorectal Cancer
provides data-driven analysis of the industry landscape, including current
trends, key players, and regional nuances. These insights offer actionable
recommendations, enabling readers to differentiate themselves from competitors
by identifying untapped segments or developing unique value propositions.
Leveraging data analytics, these insights help industry players anticipate the
market shifts, whether investors, manufacturers, or other stakeholders. A
future-oriented perspective is essential, helping stakeholders anticipate
market shifts and position themselves for long-term success in this dynamic
region. Ultimately, effective strategic insights empower readers to make
informed decisions that drive profitability and achieve their business
objectives within the market.
📚𝐅𝐮𝐥𝐥
𝐑𝐞𝐩𝐨𝐫𝐭
𝐋𝐢𝐧𝐤
@ https://www.businessmarketinsights.com/reports/north-america-colorectal-cancer-market
North America
Colorectal Cancer Market
Colorectal cancer (CRC) is one of the most commonly
diagnosed cancers in North America, and it remains a significant public health
concern due to its high incidence, mortality rates, and the economic burden it
places on healthcare systems. The North American colorectal cancer market
encompasses a wide array of diagnostic, therapeutic, and monitoring products
and services aimed at the prevention, early detection, and treatment of this
disease. In this article, we explore the market landscape, key drivers,
challenges, and emerging trends shaping the North American colorectal cancer
market.
Overview of
Colorectal Cancer
Colorectal cancer refers to cancer that begins in the colon
or rectum, both parts of the large intestine. CRC is the third most commonly
diagnosed cancer in both men and women in the United States, after breast and
prostate cancers. It is also one of the leading causes of cancer-related deaths
in the region. The disease develops when abnormal cells in the colon or rectum
grow uncontrollably, leading to the formation of tumors.
Segments Covered
By Modality
- Diagnosis
Type
- Therapy
Type
- Imaging
Type
By End User
- Hospitals
- Diagnostic
and Research Laboratories
Risk factors for colorectal cancer include age (most cases
occur in individuals aged 50 or older), family history of the disease,
lifestyle factors such as diet, smoking, physical inactivity, and obesity, as
well as conditions such as inflammatory bowel disease (IBD) and certain genetic
syndromes. Early detection through regular screenings, such as colonoscopies,
can help identify precancerous growths or cancers in their early stages,
improving treatment outcomes.
𝐓𝐡𝐞 𝐋𝐢𝐬𝐭
𝐨𝐟
𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬
Abbott
Amgen Inc.
Bruker Corporation
Clinical Genomics Technologies Pty Ltd.
Epigenomics AG
F. Hoffmann-La Roche AG
Quest Diagnostics
VolitionRx Limited
North
America Colorectal Cancer Market
Colorectal cancer (CRC) is one of
the most commonly diagnosed cancers in North America, and it remains a
significant public health concern due to its high incidence, mortality rates,
and the economic burden it places on healthcare systems. The North American
colorectal cancer market encompasses a wide array of diagnostic, therapeutic,
and monitoring products and services aimed at the prevention, early detection,
and treatment of this disease. In this article, we explore the market
landscape, key drivers, challenges, and emerging trends shaping the North
American colorectal cancer market.
Overview
of Colorectal Cancer
Colorectal cancer refers to cancer
that begins in the colon or rectum, both parts of the large intestine. CRC is
the third most commonly diagnosed cancer in both men and women in the United
States, after breast and prostate cancers. It is also one of the leading causes
of cancer-related deaths in the region. The disease develops when abnormal
cells in the colon or rectum grow uncontrollably, leading to the formation of
tumors.
Risk factors for colorectal cancer
include age (most cases occur in individuals aged 50 or older), family history
of the disease, lifestyle factors such as diet, smoking, physical inactivity,
and obesity, as well as conditions such as inflammatory bowel disease (IBD) and
certain genetic syndromes. Early detection through regular screenings, such as
colonoscopies, can help identify precancerous growths or cancers in their early
stages, improving treatment outcomes.
𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Business Market
Insights is a market research platform that provides subscription service for
industry and company reports. Our research team has extensive professional
expertise in domains such as Electronics & Semiconductor; Aerospace &
Defense; Automotive & Transportation; Energy & Power; Healthcare;
Manufacturing & Construction; Food & Beverages; Chemicals &
Materials; and Technology, Media, & Telecommunications
You can see this-
North America Tortilla Market- https://www.openpr.com/news/3927532/north-america-tortilla-market-segments-opportunities
3D and 4D Technology Market- https://www.openpr.com/news/3921417/3d-and-4d-technology-market-segments-opportunities-regional
Last Mile Delivery Market- https://www.openpr.com/news/3921138/last-mile-delivery-market-global-analysis-size-share
Comments
Post a Comment